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Abstract: 
Cardiomyopathy, a disease of the heart muscle, is associated with cardiac dysfunction and results to severe heart 
failure, arrhythmias, and death. Arrhythmogenic right ventricular cardiomyopathy (ARVC) is a familial 
cardiomyopathy that is characterized by localized movement disorder in the wall of the right ventricle. Long QT 
syndrome (LQTS) is typical cardiac arrhythmia that causes hereditary or acquired cardiac arrest in patients with long 
QT interval and can be identified by electrocardiogram. It has been elucidated that R1193Q Polymorphism (R1193Q 
GGG> CAG, rs41261344)) is a functional substitution in sodium voltage-gated channel alpha subunit 5 (SCN5A) gene, 
and correlates with cardiac arrhythmia syndromes such as ARVC and LQTS. This case-control study was conducted to 
consider the correlation between SCN5A rs41261344 and cardiac arrhythmia syndromes in Iranian population. In the 
present study, 40 patients with LQTS, and 40 patients with ARVC, and 80 healthy subjects as controls were analyzed for 
SCN5A rs41261344 by polymerase chain reaction- restriction fragment length polymorphism (RFLP-PCR) and 10 
samples from each group were sequenced. The SCN5A rs41261344 C allele with a frequency of 100% was present in all 
the patients and the healthy subjects. However, we did not observe SCN5A rs41261344 T allele in our enrolled subjects. 
In fact, the frequency of T allele was calculated zero. Regard to very low frequency of the R1193Q polymorphism minor 
allele, SCN5A rs41261344 T allele, in our cohort, it can be suggested that other mutations may be associated with 
cardiac arrhythmia syndromes such as ARVC and LQTS in Iranian population. 
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INTRODUCTION: 
Cardiovascular diseases, is the cause of 12 million fetal 
deaths annually in the United States of American and 
it’s the disorders of heart and blood vessels, are the 
main cause of mortality in modern societies [1]. 
Cardiomyopathy is discribed as a myocardial disorder 
in heart muscles is structurally abnormal and results in 
severe heart failure, arrhythmias (heart failure or 
irregular heartbeats), and finally death. The different 
cardiomyopathy types can be classified into the 
following categories: restrictive cardiomyopathy, 
hypertrophic cardiomyopathy and unclassified 
cardiomyopathy [2]. ARVC is a familial right 
ventricular dysplasia that is characterized by 
dysfunctionality of the muscular wall of the right 
ventricle. Moreover, this disorder commonly is 
indicated in males [3-5]. Imaging modalities commonly 
used for ARVC assessment contain  echocardiography, 
cardiovascular magnetic resonance (CMR), and RV 
angiography [6] structural unnatural and right 
ventricular dysfunction have been confirmed in most of 
the ARVC patients [2] SCN5A is the candidate gene 
for ARVC about 30 to50% of patients with ARVC 
have a family history of the disease. In addition, some 
of the ARVC patients with autosomal recessive pattern 
of inheritance have been reported with Naxos disease 
and Carvajal syndrome. [7-12] The SCN5A gene is 
located on chromosome 3p21 24 and belongs to a gene 
family that are coding the components of sodium 
channels. It has been shown that SCN5A gene 
expression leads to diverse isoforms of sodium 
channels i.e. brain-type, neuronal channels, skeletal 
muscle channels, and the cardiac sodium channel 
NaV1.5 These channels in heart play main roles in 
signaling of the start of each heartbeat, maintaining a 
normal heart rhythm and coordinating the contractions 
of the upper and lower chambers of the heart. The 
SCN5A gene contains 28 exons of which the exons 2 
to 28 constitute the protein-coding sequence.  More 
than 10 different splice isoforms have been described 
for SCN5A gene [13, 14] SCN5A splice variants, 
Nav1.5, functions as an electric transmission and 
produces potential impulses in the heart myocardium 
[15-17]. Also, the SCN5A gene variants might impact 
on different channel mechanisms, including its 
activation, inactivation, and reactivation. Mutations 
that impaired the Nav1.5 channel α-subunit are known 
to be considered as risk factors for arrhythmia. It is 
including 6% of patient with LQTS subtype 3 (LQTS3) 
and 10 to20% of patient with Brugada Syndrome [18-
26]. Moreover, some mutations of SCN5A gene either 
result in the biophysical deficiencies or are associated 
with an increased risk of sudden cardiac death. The 
R1193Q polymorphism (CGG>CAG, refSNP ID 
rs41261344), for instance, in SCN5A gene is the 
underpinning reason of approximately 13% of patients 
with LQTS. It is hypothesized that R1193Q 
polymorphism might increase the susceptibility to 
LQTS as a result of disturbing the sodium channel 
function [27]. Actually, R1193Q polymorphism, a 
missense mutation, results in the replacement of 
arginine with glutamine at position 1193. Thus, this 
alteration results in a non-conservative status which 
consequently causes inactivation of sodium channel 
current [28-30]. 
 
MATERIALS AND METHODS: 
Sampling 
DNA samples randomly selected from subjects referred 
to Rajaie cardiovascular medical and research center 
Written consent was obtained from all participants 
prior to blood sampling. 5 ml peripheral whole blood 
was taken from each patients (40 patients with ARVC, 
40 patients with LQTS and 80 healthy controls). All 
the patients had a familial history of heart disease, 
heart failure or an unexpected sudden cardiac death. 
The investigation included a review of clinical history, 
echocardiography, complete physical examination, and 
standard 12-lead ECG measured at rest. In some cases, 
a 24-h ambulatory ECG was measured as well. The 
normal range of the ECG measurements was based on 
the age of each person. 
DNA extraction 
Total genomic DNA was extracted from 5 ml 
peripheral whole blood. A salt precipitation method 
(salting out) was used to extract of DNA from each 
sample [31]. The purity and concentration of DNA was 
measured by using of Nano-drop device. 
PCR amplification and analyses  
Coding region (R1193Q) and intron–exon boundary in 
SCN5A gene were amplified by using the following 
primers: 
Forward primer (CAGGGAAGGTCTGGTGGC) 
Reverse primer (TCCTACTCAGCAGTGGAGCG) 
The PCR reactions were carried out in a 25 μl total 
volume containing: 1 μl of DNA genemic, 3 μl of 
master mix (Taq polymerase, MgCl2, Buffer), 0.5 μl of 
forward primer, 0.5 μl of reverse primer, and 20 μl of 
distilled water. The cycles were as: 1 cycle at 95°C for 
5 min; 30 cycles (95°C for 30 secs, 65°C for 30 secs, 
72°C for 35 secs, 72°C for 5 min).  5 ml of the PCR 
product was expanded at 100V on 1% agarose gel 
electrophoresis. Then RFLP technique was done using 
ACI1 restriction enzyme and fragments were separated. 
Data confirmation of 10% of samples was done by 
sequencing assay (Figure 1) then, the data were 
analyzed. 
 
FINDING: 
Ischemic heart disease and heart failure is the most 
common causes of sudden cardiac death. However, in 5 
to 8 % of sudden cardiac death victims, no evidence of 
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structural heart diseases was found. Ion channel 
disorders constitute 35% of causes of sudden 
unexplained death (SUD) in young people and 9% of 
sudden infant death syndrome (SIDS) that which was 
the largest LQTS [26, 32]. The R1193Q minor allele, T 
allele, was not observed in the cases and controls.  
Overall, 160 people studied population was composed 
of 80 patients and 80 healthy controls. a R1193Q 
mutation was not found in any of the 80 normal 
subjects and 80 patients, Genotypic distribution of 
R1193q polymorphism in CC Genotype (healthy) in all 
of cases (ARVC cases, Long QT cases, Control cases) 
was %100, also Genotypic distribution of R1193q 
polymorphism in CT, TT Genotype(mutant) in all of 
cases (ARVC cases, Long QT cases, Control cases) 
was %0. Also, allelic frequency of R1193q 
polymorphism in C (Healthy) allelic for Arvc cases 
was 100%, for Long QT cases 100%, also for Control 
cases was 100%, also allelic frequency of R1193q 
polymorphism for T allelic(Mutant) in Arvc cases was 
0, in Long QT cases 0 and in control cases was 0. In 
our study, the results showed that, contrary to previous 
observations in Asian countries, R1193Q 
polymorphism is not Iran's population common 
polymorphisms. According to this result, suggesting 
Contrary to the previous observations in Asian 
countries, the results of this study showed that R1193Q 
polymorphism is not common in Iranian population. 
However, the results of this study are in concordance 
with European population. 
 
DISCUSSION: 
R1193Q Polymorphism (R1193Q GGG> CAG, 
rs41261344)) is located at the interface between 
domain 2 and 3 of the SCN5A gene. The arginine 
residue at position 1193 in different isoforms of 
sodium channel is a strongly conserved site amongst 
mammalian. It seems that R1193Q missense 
substitution is a functional mutation that can result in 
sodium channel inactivation and increases 
susceptibility to LQTS [29-32]. Also, this substitution 
was detected in patients with Brugada syndrome 
R1193Q mutation (Refseq: NM – 000335) was 
reported in Japanese baby with Brugada syndrome [26, 
30 and 32]. Interestingly, the R1193Q polymorphism 
acts as a gain of function mutation in patients with 
LQTS3, whilst this functional substitution results in a 
loss of function status in patients with Brugada 
syndrome. All together, these observations suggest that 
R1193Q polymorphism could be considered as a risk 
factor in development of these diseases. Although it 
was elucidated that SCN5A gene mutations are 
involved in sudden death and also R1193Q 
replacement is common polymorphism in different 
Asian populations, we did not observe association 
between R1193Q polymorphism and the 
cardiomyopathy syndromes, LQTS and ARVC, in 
Iranian population. The geographical distribution of 
R1193Q polymorphism was analyzed in more than 
4,000 populations of Asia, Europe and Africa. In this 
context, overall, the R1193Q polymorphism might 
have several consequences, including arrhythmias, 
electrophysiological abnormality associated with heart 
disorders, and sudden death [26]. the presence of 
R1193Q polymorphism has been reported in 7 cases of 
LQTS, which is supportive of the idea that this 
mutation might increase the susceptibility to LQTS. If 
we access the variants of the genes that are involved in 
the risk of ARVC and LQTs, we would be able to use 
these genetic profiles to screen high risk families or 
even reduce the mortality of the children suffering 
from ARVC and LQTS at least in Iranian population. It 
also suggests that to approve accuracy of this study, 
further investigation with larger participant numbers is 
extremely recommended.  
 
 
Fig 1: Results of sequence SCN5A gene, R1193Q polymorphism 
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